Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax

Affiliations

• ¹ Institute of Biomedical Sciences, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
• ² Institute of Biomedical Sciences, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
• ³ Hematology and Clinical Oncology, Ribeirão Preto Medical School, Universidade de Sao Paulo, Ribeirao Preto, Sao Paulo, SP, Brazil.
• ⁴ Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
• ⁵ Institute of Biomedical Sciences, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. Electronic address: jamachadoneto@usp.br.